European Commission approves prostate cancer treatment Erleada
Erleada (apalutamide) has been approved for non-metastatic castration-resistant prostate cancer patients who are at high risk of developing metastatic disease
List view / Grid view
News
Arfolitixorin linked to tumour shrinkage in colorectal cancer
A Phase I/IIa study has shown that arfolitixorin along with either irinotecan or oxaliplatin could shrink the size of tumours in colorectal cancer patients...
Almac Group extends personalised cancer vaccine production facilities
The Almac Group, a CDMO serving the pharmaceutical and biotech sectors globally, is expanding its Edinburgh Technopole facility to allow scale-up of its personalised cancer vaccine activities...
Increases in patients combining drugs could be dangerous
Combining benzodiazepines, opioids and Z-drugs could prove to cause serious adverse outcomes including breathing problems and fatalities...
Experts push the boundaries of 3D microscopy
Researchers have developed a method that can use 3D microscopy to develop ALMOST, A Label-free Multicolor Optical Surface Tomography...
Generic version of seizure drug Sabril gets FDA approval
A generic version of the seizure drug Sabril (vigabatrin) has been approved by the FDA...
Losartan could improve ovarian cancer treatment
Researchers have found that losartan could be beneficial for those undergoing cancer treatment as it may enhance its effectiveness...
The Falsified Medicines Directive: steps to compliance
As the date of implementing the FMD comes closer, organisations need to be ensuring compliance, whether in the EU or even after a possible no-deal Brexit...
Pharma industry ‘call for action’ following Brexit vote
The pharma industry has called for the government to act to ensure that patients receive their medications in the case of a ‘no deal’ situation...
Oversight committee launches sweeping drug price investigation
Chairman of the Committee on Oversight and Reform sends detailed requests to 12 pharmaceutical companies about increasing drug prices...
Inhaled dry powder formulation of treprostinil works well in PAH patients
A formulation of treprostinil as an inhaled dry powder has proven to be safe and effective, as reported in the safety analysis of a Phase III trial...
NewAge® Industries celebrates its 65th anniversary
NewAge Industries has reached another significant event in its history: 2019 marks the company’s 65th year in business...
Developing the production of the radioisotope Tc-99m within the US
A team of university researchers have collaborated together to develop a method to produce the radioisotope Tc-99m in the US to prevent having to import it...
Examining the course of back pain over time
Researchers have investigated back pain, and the disability, opioid and other medication use associated with it, to identify its course over time...
Millions on insomnia drug would sleep through a fire alarm
A study has reported that millions currently taking benzodiazepines to help them sleep would not hear a fire alarm, thus warning of possible dangers...
